UF Health Cancer Center Support Grant - Training Navigator Supplement

佛罗里达大学健康癌症中心(UFHCC)认识到，实现健康公平需要 全纳教育、培训、招聘、留用和提拔下一代癌症研究人员。 因此，本行政副刊申请旨在招聘和发展一支独立的干部队伍 研究人员准备解决我们集水区癌症差异的问题。这份补充资料将加强 CARTEC、DEI和佛罗里达-加州癌症研究、教育和参与项目的协同影响 (Care2)健康公平中心，重点发展代表不足的少数群体(URM)博士前、博士后、 和早期调查人员(Esis)。在CARTEC和CARE2的成功基础上进行扩展，并实现其 为了改善URM学员和ESIS的培训结果，一个培训导航员团队(TNT)将 实施以1)在UFCC的CARTEC、DEI和Care2计划之间架起桥梁；2)促进 URM进入癌症研究培训渠道；3)为受训人员和EIS做好职业发展的准备 该中心提供的发展机会，以减少癌症健康差距治疗计划和 更远一点。这种合作努力寻求通过以下方式在每个项目的成功基础上再接再厉 目标：1)实施TNT，以吸引、招募和支持竞争激烈、代表性不足的学员和EIS， 并为他们进入加州大学旧金山分校的NIH支持的路径项目和获得NCI资金提供便利； 2)通过撰写赠款和技术支持，为学者提供专业准备和网络机会 援助讲习班(TAWS)；以及3)监测、跟踪和评估受训人员的进展和生产力以及 艾西斯。特别是，TNT将帮助从与MSI合作的地区以及全国范围内招募URM实习生 展示小规模本科生研究人员工作的会议。此外，一系列5个培训 将举办援助讲习班(TAWS)，为学员和ESIS寻求治疗资金做好准备。全 TAWS将被录制，内容将被用来开发一个创新的混合和异步课程， 将通过该大学的基于网络的学习管理系统提供。指标将在新的 已提交的与癌症有关的奖项和出版物、提案和补充资料以及相应的资金 评级，并为学员提供辅导活动。使用CPACHE U54研究教育共享的评估 MEASURES工具包还将确定拟议活动对供资和职业发展的影响。这 应用程序意义重大，因为它将增加UFCC的URM实习生数量，增加 对URM-和癌症差异-相关资金的认识，并提高URM UFCC的能力 受训人员寻求外部资金。这一计划将产生影响，因为它将帮助招聘15名毕业后的毕业生， 博士后、博士后和研究员，并将在陶斯聘用40名博士后、博士后、研究员和Esis 2023-2024年共提交10份治愈支持申请。

The University of Florida Health Cancer Center (UFHCC) recognizes that achieving health equity requires inclusive education, training, recruitment, retention, and promotion of the next generation of cancer researchers. Therefore, this Administrative Supplement application aims to recruit and develop a cadre of independent researchers prepared to address cancer disparities in our catchment area. This supplement will enhance the synergistic impact of CaRTEC, DEI, and the Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center by focusing on developing underrepresented minority (URM) pre-doc, post-doc, and early-stage investigators (ESIs). To expand upon the success of CaRTEC and CaRE2, and achieve their long-term goal of improving training outcomes of URM trainees and ESIs, a Training Navigator Team (TNT) will be implemented to 1) bridge activities between CaRTEC, DEI, and CaRE2 programs at the UFHCC; 2) facilitate the entry of URM into the cancer research training pipeline; and 3) prepare trainees and ESIs to pursue career development opportunities provided by the Center to Reduce Cancer Health Disparities CURE program and beyond. This collaborative effort seeks to build upon the successes of each program through the following objectives: 1) implement a TNT to attract, recruit, and support competitive underrepresented trainees and ESIs, and facilitate their entry into NIH-supported pathway programs at the UFHCC and the attainment of NCI funding; 2) provide professional preparation and networking opportunities for scholars through grant writing and technical assistance workshops (TAWs); and 3) monitor, track, and evaluate the progress and productivity of trainees and ESIs. In particular, the TNT will help recruit URM trainees regionally, from partnering MSIs, as well as national conferences to exhibit the work of minoritized undergraduate researchers. In addition, a series of 5 training assistance workshops (TAWs) will be developed to prepare trainees and ESIs to pursue CURE funding. All TAWs will be recorded and content will be used to develop an innovative hybrid and asynchronous course that will be offered through the University's web-based learning management system. Metrics will be tracked on new cancer-relevant awards and publications, proposals and supplements submitted and the corresponding funding rate, and mentorship activities for trainees. Evaluations using the CPACHE U54 Research Education Shared Measures Toolkit will also determine the impact of proposed activities on funding and career development. This application is significant because it will increase the number of URM trainees at the UFHCC, increase the awareness around URM- and cancer disparities-relevant funding, and improve the capacity for URM UFHCC trainees to pursue external funding. This program will be impactful because it will help recruit >15 post-bacs, pre-docs, post-docs, and fellows and will engage >40 pre-docs, post-docs, fellows, and ESIs in TAWs who will submit a total of 10 CURE-supported applications in 2023-2024.